Inventor · disambiguated record
Michael F. Parker
Also filed as: PARKER MICHAEL F · PARKER MICHAEL FREDERICK · PARKER MICHAEL W
20 granted patents·3 pending applications·306 citations·filing 1995–2023
95Inventor score
Files withBRISTOL MYERS SQUIBB CO16PARKER MICHAEL F2BIOTA HOLDINGS LTD1BRISTOL MYERS SQUIBB COMPNAY1DEGNAN ANDREW P1
Top patents by PatentIndex Score
23 records- 0193US5856529ABenzofuran and dihydrobenzofuran melatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jan 5, 1999·112 cites·15 claims
- 0291US7300936B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 27, 2007·46 cites·24 claims
- 0388US7786122B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 31, 2010·12 cites·1 claims
- 0485US5753709AN-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergicsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted May 19, 1998·25 cites·19 claims
- 0583US6967196B1Sulfonamide compounds and uses thereofMERCK & CO INC·Filed 2000·Granted Nov 22, 2005·24 cites·4 claims
- 0682US5596019AN-acyl-cycloalkylamine derivatives as melatonergicsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jan 21, 1997·24 cites·12 claims
- 0779US10968219B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 6, 2021·2 cites·16 claims
- 0871US8691821B2Oxazolidinones as modulators of mGluR5DEGNAN ANDREW P·Filed 2011·Granted Apr 8, 2014·3 cites·14 claims
- 0970US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 1069US5889031AN-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergicsBRISTOL MYERS SQUIBB COMPNAY·Filed 1998·Granted Mar 30, 1999·10 cites·5 claims
- 1168USRE49735EOxazolidinones as modulators of MGLUR5BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 28, 2023·0 cites·16 claims
- 1267US9688669B2Oxazolidinones as modulators of mGluR5BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 27, 2017·1 cites·12 claims
- 1365US2025263424A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1464US6989399B2Antiamyloid phenylsulfonamides: N-alkanol derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 24, 2006·3 cites·6 claims
- 1564US5541228AMelatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jul 30, 1996·21 cites·17 claims
- 1662US5661185AMelatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Aug 26, 1997·8 cites·7 claims
- 1761US11884661B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 30, 2024·0 cites·11 claims
- 1855US6060506ABenzopyran derivatives as melatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted May 9, 2000·9 cites·8 claims
- 1946US8513253B2α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitorsPARKER MICHAEL F·Filed 2010·Granted Aug 20, 2013·0 cites·3 claims
- 2045US5981571ABenzodioxa alkylene ethers as melatonergic agentsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Nov 9, 1999·4 cites·11 claims
- 2142US2008027056A1Substituted heterocyclic ethers and their use in cns disordersBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2241US8071778B2Substituted heterocyclic ethers and their use in CNS disordersPARKER MICHAEL F·Filed 2008·Granted Dec 6, 2011·0 cites·10 claims
- 2332US2005221285A1Method for identifying or screening anti-viral agentsBIOTA HOLDINGS LTD·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael F. Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →